Signature-based repurposed drugs resemble the inhibition of TGFβ-induced NDRG1 as potential therapeutics for triple-negative breast cancer.
基于特征的再利用药物类似于抑制 TGFβ 诱导的 NDRG1，可作为三阴性乳腺癌的潜在疗法
期刊:International Journal of Biological Sciences
影响因子:10
doi:10.7150/ijbs.112645
López-Tejada Araceli, Blaya-Cánovas Jose L, Cara Francisca E, Calahorra Jesús, RamÃrez-Tortosa César, Blancas Isabel, Delgado-Almenta Violeta, Muñoz-Parra Fabiola, Ãvalos-Moreno Marta, Sánchez Ana, González-González Adrián, Marchal Juan A, Griñán-Lisón Carmen, Granados-Principal Sergio
